Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial-Reference-Cited by-同舟云学术

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

Published:2003-09 Issue:9386 Volume:362 Page:772-776
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Granger Christopher B,McMurray John JV,Yusuf Salim,Held Peter,Michelson Eric L,Olofsson Bertil,Östergren Jan,Pfeffer Marc A,Swedberg Karl

Publisher

Elsevier BV

Subject

General Medicine

Reference19 articles.

1. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure: Collaborative Group on ACE Inhibitor Trials;Garg;JAMA,1995

2. Contemporary management of patients with left ventricular svstolic dysfunction: results from the study of patients intolerant of converting enzyme inhibitors (SPICE) registry;Bart;Eur Heart J,1999

3. The EuroHeart Failure survey programme: a survey on the quality of care among patients with heart failure in Europe, part 1—patient characteristics and diagnosis;Cleland;Eur Heart J,2003

4. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey;Cleland;Lancet,2002

5. Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD): SOLVD Investigators;Kostis;Am Heart J,1996

Cited by 1567 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of NAD+ in Myocardial Ischemia-induced Heart Failure in Sprague-dawley Rats and Beagles;Current Pharmaceutical Biotechnology;2024-12

2. Looking for the ideal medication for heart failure with reduced ejection fraction: a narrative review;Frontiers in Cardiovascular Medicine;2024-09-06

3. Why Have We Not Been Able to Demonstrate Reduced Mortality in Patients With HFmrEF/HFpEF?;Journal of the American College of Cardiology;2024-09

4. 2024 ESC Guidelines for the management of chronic coronary syndromes;European Heart Journal;2024-08-30

5. Update on clinical and experimental management of diabetic cardiomyopathy: addressing current and future therapy;Frontiers in Endocrinology;2024-07-30